266 related articles for article (PubMed ID: 9461127)
1. Increased expression of placenta growth factor in proliferative diabetic retinopathy.
Khaliq A; Foreman D; Ahmed A; Weich H; Gregor Z; McLeod D; Boulton M
Lab Invest; 1998 Jan; 78(1):109-16. PubMed ID: 9461127
[TBL] [Abstract][Full Text] [Related]
2. VEGF localisation in diabetic retinopathy.
Boulton M; Foreman D; Williams G; McLeod D
Br J Ophthalmol; 1998 May; 82(5):561-8. PubMed ID: 9713066
[TBL] [Abstract][Full Text] [Related]
3. A comparison of hypoxia-inducible factor-α in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients.
Lim JI; Spee C; Hinton DR
Retina; 2010 Oct; 30(9):1472-8. PubMed ID: 20811317
[TBL] [Abstract][Full Text] [Related]
4. Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy.
Smith G; McLeod D; Foreman D; Boulton M
Br J Ophthalmol; 1999 Apr; 83(4):486-94. PubMed ID: 10434875
[TBL] [Abstract][Full Text] [Related]
5. The angiogenic biomarker endocan is upregulated in proliferative diabetic retinopathy and correlates with vascular endothelial growth factor.
Abu El-Asrar AM; Nawaz MI; De Hertogh G; Al-Kharashi AS; Van den Eynde K; Mohammad G; Geboes K
Curr Eye Res; 2015 Mar; 40(3):321-31. PubMed ID: 24871583
[TBL] [Abstract][Full Text] [Related]
6. Expression of stromal cell-derived factor-1 in diabetic retinopathy.
Chen LY; Zhuo YH; Li YH; Huang XH; Zhang JL; Li SY; Wang XG; Lü L
Chin Med J (Engl); 2010 Apr; 123(8):984-8. PubMed ID: 20497701
[TBL] [Abstract][Full Text] [Related]
7. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
8. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
9. Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes.
Frank RN; Amin RH; Eliott D; Puklin JE; Abrams GW
Am J Ophthalmol; 1996 Sep; 122(3):393-403. PubMed ID: 8794712
[TBL] [Abstract][Full Text] [Related]
10. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-14 is a biomarker of angiogenic activity in proliferative diabetic retinopathy.
Abu El-Asrar AM; Mohammad G; Allegaert E; Ahmad A; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
Mol Vis; 2018; 24():394-406. PubMed ID: 29853773
[TBL] [Abstract][Full Text] [Related]
13. (Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy.
Kanda A; Noda K; Saito W; Ishida S
Diabetologia; 2012 Nov; 55(11):3104-13. PubMed ID: 22930161
[TBL] [Abstract][Full Text] [Related]
14. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Matsui S; Kurimoto M; Kiryu J; Kita M; Suzuma I; Ohashi H; Ojima T; Murakami T; Kobayashi T; Masuda S; Nagao M; Yoshimura N; Takagi H
N Engl J Med; 2005 Aug; 353(8):782-92. PubMed ID: 16120858
[TBL] [Abstract][Full Text] [Related]
16. Indications of lymphatic endothelial differentiation and endothelial progenitor cell activation in the pathology of proliferative diabetic retinopathy.
Loukovaara S; Gucciardo E; Repo P; Vihinen H; Lohi J; Jokitalo E; Salven P; Lehti K
Acta Ophthalmol; 2015 Sep; 93(6):512-23. PubMed ID: 25899460
[TBL] [Abstract][Full Text] [Related]
17. The expression of the Slit-Robo signal in the retina of diabetic rats and the vitreous or fibrovascular retinal membranes of patients with proliferative diabetic retinopathy.
Zhou W; Wang H; Yu W; Xie W; Zhao M; Huang L; Li X
PLoS One; 2017; 12(10):e0185795. PubMed ID: 28973045
[TBL] [Abstract][Full Text] [Related]
18. Vitreous and plasma concentrations of apelin and vascular endothelial growth factor after intravitreal bevacizumab in eyes with proliferative diabetic retinopathy.
Qian J; Lu Q; Tao Y; Jiang YR
Retina; 2011 Jan; 31(1):161-8. PubMed ID: 20890241
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
[TBL] [Abstract][Full Text] [Related]
20. Intraocular oxygen distribution in advanced proliferative diabetic retinopathy.
Lange CAK; Stavrakas P; Luhmann UFO; de Silva DJ; Ali RR; Gregor ZJ; Bainbridge JWB
Am J Ophthalmol; 2011 Sep; 152(3):406-412.e3. PubMed ID: 21723532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
